Crescent Biopharma CBIO
NASDAQ CBIO
$13.17 +0.10 (+0.77%)
At close: Oct 21, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Other financing activities (2024 - 2026)

Updated

Crescent Biopharma (CBIO) posted Other financing activities of $175,000 for Q2 2025.

Analysis

Crescent Biopharma (CBIO) Other financing activities (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Crescent Biopharma 401.19 Mn -306.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -144,000.00
Mar 31, 2026 -6.95 Mn
Jun 30, 2025 1.31 Mn
Mar 31, 2025 -1.49 Mn
Dec 31, 2024 -760,000.00
API Access

Crescent Biopharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CBIO&period=max&api_key=YOUR_API_KEY